Argus II Retinal Prosthesis System Dry AMD Feasibility Study Protocol

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2019

Study Completion Date

March 31, 2020

Conditions
Age Related Macular Degeneration
Interventions
DEVICE

Effect of Argus II on Functional Vision

To evaluate the safety and effectiveness of the Argus II Retinal Prosthesis in subjects with AMD.

Trial Locations (1)

M13 9WL

Manchester Royal Eye Hospital, Manchester

All Listed Sponsors
lead

Second Sight Medical Products

INDUSTRY

NCT02227498 - Argus II Retinal Prosthesis System Dry AMD Feasibility Study Protocol | Biotech Hunter | Biotech Hunter